East Timor Business Daily
SEE OTHER BRANDS

Hottest business and economy news from East Timor

East Timor Business Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on East Timor Business Daily.

Press releases published on June 2, 2025

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting

- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …

Sutro Biopharma Appoints Greg Chow as Chief Financial Officer

Sutro Biopharma Appoints Greg Chow as Chief Financial Officer

SOUTH SAN FRANCISCO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of  …

Xunlei Closes Acquisition of Hupu

Xunlei Closes Acquisition of Hupu

SHENZHEN, China, June 02, 2025 (GLOBE NEWSWIRE) -- Xunlei Limited ("Xunlei" or the "Company") (Nasdaq: XNET), a leading technology company providing distributed cloud services in China, today announced that it has closed the acquisition of Shanghai …

Freehold Royalties Announces Appointment of Chief Financial Officer

Freehold Royalties Announces Appointment of Chief Financial Officer

CALGARY, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) is pleased to announce the appointment of Shaina Morihira as its Chief Financial Officer, effective June 4, 2025. Ms. Morihira will succeed …

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

DURHAM, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced that its abstract on the V007 …

Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference

Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference

CONSHOHOCKEN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46th Annual Global Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40 A.M. …

Crawford United Corporation Publishes Investor Presentation on Company Website

Crawford United Corporation Publishes Investor Presentation on Company Website

CLEVELAND, June 02, 2025 (GLOBE NEWSWIRE) -- Crawford United Corporation (OTC: CRAWA) announced today that contemporaneously with this press release it has posted investor presentation materials containing supplemental information for investors and other …

Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001

Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001

Both ERAS-4001 and potential best-in-class pan-RAS molecular glue ERAS-0015 received IND clearance in May ahead of company guidance Initial Phase 1 monotherapy data for both RAS-targeting programs expected in 2026 SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) …

Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer

Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer

CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Stratus Therapeutics, Inc. (“Stratus”), a biotechnology company developing on-demand hematopoietic stem cell (HSC) therapies, today announced the appointment of Michael (Mike) P. Cooke, PhD, as Chief …

WSP acquiert Lexica, une firme de services-conseils spécialisée en soins de santé et en sciences de la vie

WSP acquiert Lexica, une firme de services-conseils spécialisée en soins de santé et en sciences de la vie

MONTRÉAL, 02 juin 2025 (GLOBE NEWSWIRE) -- Groupe WSP Global Inc. (TSX : WSP) (« WSP » ou la « Société »), l’une des plus importantes firmes de services professionnels au monde, annonce l’acquisition de Lexica, une entreprise de services-conseils du …

Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting

Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic …

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

ORLANDO, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the first quarter ended April 30, 2025. Nutriband is continuing to expand its kinesiology tape output through its Pocono Pharma …

GRR! Rebrands to Heidelberg Materials

GRR! Rebrands to Heidelberg Materials

Irving, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Heidelberg Materials North America is pleased to announce that its recently acquired subsidiary, Giant Resource Recovery (GRR!), will rebrand to Heidelberg Materials Giant Resource Recovery (GRR) effective …

Solésence Expands Debt Facilities to Fuel Growth Initiatives

Solésence Expands Debt Facilities to Fuel Growth Initiatives

ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its …

WSP acquires specialist healthcare and life sciences consulting firm Lexica

WSP acquires specialist healthcare and life sciences consulting firm Lexica

MONTREAL, June 02, 2025 (GLOBE NEWSWIRE) -- WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”), one of the world's leading professional services firms, announces the acquisition of Lexica, a UK-based consulting firm specializing in healthcare and life …

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Jefferies Global Healthcare Conference, being held at the …

Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors

Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), is pleased to announce that Mr. Michael Mulberry has been appointed to the board of directors of the …

Oportun Issues Letter to Stockholders and Mails Definitive Proxy Materials

Oportun Issues Letter to Stockholders and Mails Definitive Proxy Materials

Highlights strong momentum in driving profitable growth and delivering stockholder value Urges stockholders to vote “FOR” Oportun’s two highly qualified nominees – Raul Vazquez and Carlos Minetti – on the GREEN proxy card Launches VoteForOportun.com, …

Talisker Announces Upsize of Non-Brokered Private Placement for Gross Proceeds of up to $14 Million

Talisker Announces Upsize of Non-Brokered Private Placement for Gross Proceeds of up to $14 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX: TSK, OTCQX: TSKFF) is pleased to announce that as a …

Animal Nutrition Chemicals Market Size Worth USD 77.32 Billion by 2031, Rising Requirement for High Quality and Nutritious Animal Feed Fuels the Demand | The Insight Partners

Animal Nutrition Chemicals Market Size Worth USD 77.32 Billion by 2031, Rising Requirement for High Quality and Nutritious Animal Feed Fuels the Demand | The Insight Partners

US …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service